Clinical Trial: Efficacy of CL22205 on Bone Mineral Density and Menopausal Symptoms

U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06899243) titled 'Efficacy of CL22205 on Bone Mineral Density and Menopausal Symptoms' on March 01.

Brief Summary: The purpose of this study is to evaluate the effect of CL22205 on bone mineral density and menopausal symptoms in women.

Study Start Date: March 25

Study Type: INTERVENTIONAL

Condition: Menopausal Symptoms

Intervention: DIETARY_SUPPLEMENT: CL22205

200 mg, Route : Oral, One capsule a day after breakfast for 360 days

OTHER: Placebo

Route : Oral, One capsule a day after breakfast for 360 days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eetho Brands, Inc

Disclaimer: Curated by HT Syndication....